The Texas Rangers are shifting gears this offseason, and it’s a move that’s raising eyebrows across the league. While they’ve been active in reshaping their roster, the focus is now squarely on pitching, leaving many to wonder: Are they done bolstering their batting lineup? But here’s where it gets controversial—is this a strategic masterstroke or a risky gamble that could cost them next season? Let’s dive in.
The Rangers’ offseason has been anything but quiet, though it pales in comparison to their jaw-dropping half-billion-dollar spending spree that landed stars like Corey Seager, Marcus Semien, and Jon Gray. This time around, Texas has made one significant trade—swapping Semien for Brandon Nimmo—and signed four free agents to major league deals: Danny Jansen, Chris Martin, Alexis Diaz, and Tyler Alexander. They’ve also made multiple waiver claims, including Michel Otañez, Willie MacIver, and Zak Kent. Yet, despite these moves, the team’s president of baseball operations, Chris Young, recently hinted that their position player group is likely set, with pitching taking center stage. And this is the part most people miss—Young didn’t completely shut the door on further additions, but his focus is clear.
On the surface, this decision makes sense. Nimmo slots seamlessly into the lineup, replacing the non-tendered Adolis Garcia. Jansen steps in as the primary catcher, filling the void left by Jonah Heim. Second base is expected to be handled internally, with Josh Smith as the frontrunner. Corey Seager and Wyatt Langford, the team’s top hitters last season, will anchor the lineup once again. Even Evan Carter, despite a dip in performance, remains a solid contributor when healthy. Josh Jung, Jake Burger, and Joc Pederson—all struggling in recent years—are being given another chance to rebound. Pederson, in particular, seems to have no other option, given his hefty $18.5MM salary for 2026.
But here’s the catch: the Rangers’ infield corners and bench depth remain question marks. Adding another bat—someone versatile enough to play first, second, or third base—could be a game-changer. Yet, the team appears to be scaling back payroll, with projections placing them around $176MM, a $40MM drop from the 2025 season. This raises a thought-provoking question: Are the Rangers prioritizing financial caution over on-field improvement? Or is this a calculated risk, banking on their current roster to step up?
Pitching, however, is where the Rangers seem most vulnerable. Their rotation boasts an impressive top three with Jacob deGrom, Nathan Eovaldi, and Jack Leiter. But depth is a concern. Left-hander Cody Bradford is out until the second half due to surgery, leaving the team reliant on prospects like Kumar Rocker, Jacob Latz, and Jose Corniell to fill the gaps. Rocker, while promising, has yet to prove himself in the majors, and Latz’s stellar 2.84 ERA last season isn’t backed by his other stats. Meanwhile, deGrom and Eovaldi’s injury histories loom large, making the rotation feel like a house of cards.
The bullpen isn’t without its own uncertainties. While Robert Garcia, Cole Winn, and new additions like Diaz and Alexander are in the mix, there are still unsettled spots. Winn’s sub-2.00 ERA last season may not be sustainable, and Rule 5 pick Carter Baumler’s role remains uncertain. Adding another reliever or a veteran starter like Patrick Corbin, Chris Paddack, or Aaron Civale could provide much-needed stability.
So, is the Rangers’ focus on pitching a wise move, or are they overlooking a critical need for more offensive firepower? It’s a debate that’s sure to divide fans and analysts alike. What’s your take? Do you think the Rangers are making the right call, or should they reconsider their strategy? Let’s hear it in the comments!
